Testosterone Treatment Linked to Reduced Inhaled Steroid Use
Men receiving systemic testosterone therapy showed a statistically significant decrease in inhaled corticosteroid use starting 18 to 24 months after treatment initiation.
Men receiving systemic testosterone therapy showed a statistically significant decrease in inhaled corticosteroid use starting 18 to 24 months after treatment initiation.
Men receiving systemic testosterone therapy showed a statistically significant decrease in inhaled corticosteroid use starting 18 to 24 months after treatment initiation.
Read MorePulling Flovent from the market in 2024 resulted in GSK profits and harm to pediatric asthma patients, according to a US Senate investigation reported by CNN.
Read MoreStudy suggests the 2024 withdrawal of the asthma medication Flovent was linked to increases in children discontinuing inhaled steroid therapy.
Read More